Investor directory

Leaps by Bayer

CVCLeverkusen, Germanyleaps.bayer.comLinkedIn

Leaps by Bayer aims to solve ten of the world's biggest challenges through scientific breakthroughs in health and agriculture.

What they invest in

Geographies

North AmericaEurope

The facts

Typical cheque
€1M – €30M
Founded
2015

Portfolio companies

More portfolio companies

Arvinas (NAS: ARVN)TranscarentMetagenomi Therapeutics (NAS: MGX)BlueRock TherapeuticsCelea TherapeuticsRecursion Pharmaceuticals (NAS: RXRX)AgBiomeCentury Therapeutics (NAS: IPSC)Paratus SciencesTriumviraPairwiseReCode TherapeuticsCurie.BioDewpoint TherapeuticsCapstan TherapeuticsAffini-TAda HealthNumerion LabsSound AgricultureEgenesisSoufflé TherapeuticsOne DropNextPointBoundless Bio (NAS: BOLD)

and 25 more

Questions founders ask

How much does Leaps by Bayer typically invest?
Leaps by Bayer states a typical cheque of €1M – €30M.
Which stages does Leaps by Bayer invest in?
Leaps by Bayer invests at Seed and Series A.
Where is Leaps by Bayer based?
Leaps by Bayer is headquartered in Leverkusen, Germany.

Does Leaps by Bayer fit your round?

In 30 minutes you'll know which funds matter for your round.

Get a demo

Search investors like this in Claude — no account, no sign-in. Open in Claude

Are you Leaps by Bayer? Tell us what to correct and we will update it — or ask us to remove the entry.